ABIVAX: Update of Share Capital and Voting Rights

ABIVAX published information on its share capital on November 27, 2024. The share capital amounts to €633,478.37, with a total of 63,294,653 shares as of October 31, 2024. Each share is associated with a theoretical voting right, thus totaling 70,937,877 theoretical voting rights. These voting rights are used to calculate threshold crossings.

The same number of voting rights, 70,937,877, is also qualified as exercisable, excluding shares deprived of voting rights. ABIVAX communicates these figures following the recommendation of the AMF to ensure transparency. The company is listed on Euronext Paris under the symbol ABVX and continues to focus its development on treatments for chronic inflammatory diseases.